Screening and confirmation methods of the major urinary metabolite of finasteride–carboxy-finasteride by liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
Screening and confirmation methods of the major urinary metabolite of finasteride–carboxy-finasteride for doping control purpose were developed. Liquid–liquid extraction was adopted for the sample preparation. Analytes were detected by positive electrospray ionization in single quadrupole and triple...
Main Author: | Jianli Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383512000354 |
Similar Items
-
Development of the Liquid Chromatography Tandem Mass Spectrometry Method for Determination of Chloroquine and Desethylchloroquine in Human Plasma
by: Rasda Boonprasert, et al.
Published: (2020-07-01) -
Finasteride adverse effects and post-finasteride syndrome; implications for dentists
by: Stana Paunica, et al.
Published: (2016-04-01) -
Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry
by: Yiping Zhang, et al.
Published: (2015-10-01) -
Determination of repaglinide in human plasma by high-performance liquid chromatography–tandem mass spectrometry
by: Jie Zhang, et al.
Published: (2011-06-01) -
Gluten Detection and Speciation by Liquid Chromatography Mass Spectrometry (LC-MS/MS)
by: Stephen Lock
Published: (2013-12-01)